- Home
- VERV vs CLPT Comparison
VERV vs CLPT Comparison
Compare VERV & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- CLPT
- Stock Information
- Founded
- VERV 2018
- CLPT 1998
- Country
- VERV United States
- CLPT United States
- Employees
- VERV N/A
- CLPT N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- CLPT Medical/Dental Instruments
- Sector
- VERV Health Care
- CLPT Health Care
- Exchange
- VERV Nasdaq
- CLPT Nasdaq
- Market Cap
- VERV 382.5M
- CLPT 355.7M
- IPO Year
- VERV 2021
- CLPT N/A
- Fundamental
- Price
- VERV $4.79
- CLPT $10.93
- Analyst Decision
- VERV Strong Buy
- CLPT Strong Buy
- Analyst Count
- VERV 4
- CLPT 2
- Target Price
- VERV $25.75
- CLPT $12.00
- AVG Volume (30 Days)
- VERV 1.4M
- CLPT 253.7K
- Earning Date
- VERV 11-05-2024
- CLPT 11-07-2024
- Dividend Yield
- VERV N/A
- CLPT N/A
- EPS Growth
- VERV N/A
- CLPT N/A
- EPS
- VERV N/A
- CLPT N/A
- Revenue
- VERV $24,396,000.00
- CLPT $30,429,000.00
- Revenue This Year
- VERV $84.66
- CLPT $34.39
- Revenue Next Year
- VERV N/A
- CLPT $19.93
- P/E Ratio
- VERV N/A
- CLPT N/A
- Revenue Growth
- VERV 219.91
- CLPT 36.34
- 52 Week Low
- VERV $4.31
- CLPT $5.04
- 52 Week High
- VERV $19.34
- CLPT $14.13
- Technical
- Relative Strength Index (RSI)
- VERV 32.80
- CLPT 38.83
- Support Level
- VERV $6.02
- CLPT $10.81
- Resistance Level
- VERV $6.68
- CLPT $12.82
- Average True Range (ATR)
- VERV 0.47
- CLPT 0.87
- MACD
- VERV -0.14
- CLPT -0.27
- Stochastic Oscillator
- VERV 0.25
- CLPT 21.02
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.